Advertisement
| becton dickinson certificate of analysis: The Army Lawyer , 1995 |
| becton dickinson certificate of analysis: Index of Patents Issued from the United States Patent and Trademark Office , 1976 |
| becton dickinson certificate of analysis: Journal of the National Cancer Institute , 2001 |
| becton dickinson certificate of analysis: Hospital Group Purchasing United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Business Rights, and Competition, 2003 |
| becton dickinson certificate of analysis: Köhler's Invention Klaus Eichmann, 2005-07-19 Georges Köhler was one of the most prominent German scientists of recent history. In 1984, at an age of 38, he received the Nobel Prize in Physiology or Medicine, together with N.K. Jerne and C. Milstein, for inventing the technique for generating monoclonal antibodies. This method and its subsequent applications had an enormous impact on basic research, medicine and the biotech industry. In the same year, Köhler became one of the directors of the Max-Planck-Institute of Immunobiology in Freiburg; his unfortunate premature death in 1995 set an end to his extraordinary career. Prof. Klaus Eichmann, who had invited Köhler to become his codirector, is one of the people who were closest to him. This scientific biography commemorates the 10th anniversary of Köhler's untimely death. Köhler's scientific achievements are explained in a way to make them understandable for the general public and discussed in the historical context of immunological research. |
| becton dickinson certificate of analysis: Environmental Health Perspectives , 1993 |
| becton dickinson certificate of analysis: Establishments and Products Licensed Under Section 351 of the Public Health Service Act , 1983 |
| becton dickinson certificate of analysis: Code of Federal Regulations , 1990 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
| becton dickinson certificate of analysis: Federal Register , 2012-11 |
| becton dickinson certificate of analysis: Medical Laboratory Automation, Inc. V. Labcon, Inc , 1980 |
| becton dickinson certificate of analysis: Bone marrow adiposity: Contributions to bone, aging, and beyond Jason Horton, Andre J. van Wijnen, Sarah Beck-Cormier, 2023-05-24 |
| becton dickinson certificate of analysis: Building a Comprehensive IT Security Program Jeremy Wittkop, 2016-08-05 This book explains the ongoing war between private business and cyber criminals, state-sponsored attackers, terrorists, and hacktivist groups. Further, it explores the risks posed by trusted employees that put critical information at risk through malice, negligence, or simply making a mistake. It clarifies the historical context of the current situation as it relates to cybersecurity, the challenges facing private business, and the fundamental changes organizations can make to better protect themselves. The problems we face are difficult, but they are not hopeless. Cybercrime continues to grow at an astounding rate. With constant coverage of cyber-attacks in the media, there is no shortage of awareness of increasing threats. Budgets have increased and executives are implementing stronger defenses. Nonetheless, breaches continue to increase in frequency and scope. Building a Comprehensive IT Security Program shares why organizations continue to fail to secure their critical information assets and explains the internal and external adversaries facing organizations today. This book supplies the necessary knowledge and skills to protect organizations better in the future by implementing a comprehensive approach to security. Jeremy Wittkop’s security expertise and critical experience provides insights into topics such as: Who is attempting to steal information and why? What are critical information assets? How are effective programs built? How is stolen information capitalized? How do we shift the paradigm to better protect our organizations? How we can make the cyber world safer for everyone to do business? |
| becton dickinson certificate of analysis: Nano- and Microparticle-Induced Cell Death, Inflammation and Immune Responses Shrikant R. Mulay, Martin Herrmann, Rostyslav Bilyy, Alexander Gabibov, Hans-Joachim Anders, 2019-07-19 Nano- and microparticles including crystals, synthetic biomaterials, misfolded proteins or environmental particulates are involved in a wide range of biological processes and diseases. They may present as intrinsic or environmental toxins but may also be applied intentionally, e.g. as immune adjuvants, drug carriers or ion exchangers. The discovery that a wide range of nano- and microparticles share the capacity to induce IL-1β secretion via activation of the NLRP3 inflammasome in dendritic cells and macrophages has led to the hypothesis that nano- and microparticles may contribute in a uniform mechanistic manner to different disease entities. Other molecular mechanisms triggered by a range nano- and microparticles have also recently been identified including (i) the induction of regulated necrosis; (ii) neutrophil extracellular trap (NET) formation and (iii) foreign body granuloma formation as a mechanism of persistent tissue inflammation and scarring. Research on the biology of nano- and microparticle handling is currently under intense investigation. The cell type-specific responses of nano- and microparticle exposure deserves careful attention as well as the related secondary responses to these particles that lead to tissue remodeling. The immune system is at the center of these processes in terms of particle clearance, particle-induced cell death and inflammation, thereby limiting particle-related inflammation and orchestrating wound healing responses. In this Research Topic, we welcomed the submission of Original Research, Review and Mini-Review articles that addressed the significance of the immune system in particle-induced cell death, inflammation and immune responses. These findings will help facilitate new approaches to the prevention and management of particle-related diseases. |
| becton dickinson certificate of analysis: Clinical Laboratory Reference , 1999 Laboratory products and services currently available in the United States. Product information section arranged alphabetically by companies. Entries include description and ordering information. Indexes by manufactures; brand names; and test, equipment, and services. Product photograph section. |
| becton dickinson certificate of analysis: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation Dominik Schneidawind, Everett Meyer, 2020-05-22 |
| becton dickinson certificate of analysis: Tissue Remodeling in Health and Disease Caused by Bacteria, Parasites, Fungi, and Viruses Sigrun Lange, Marcel I. Ramirez, 2021-03-09 |
| becton dickinson certificate of analysis: Medical Supply Catalog Health and Human Services Supply Service Center (U.S.), 1996* |
| becton dickinson certificate of analysis: Hospital Group Purchasing United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Competition Policy, and Consumer Rights, 2004 |
| becton dickinson certificate of analysis: The Hart-Scott-Rodino Antitrust Improvements Act of 1976 , 1987 |
| becton dickinson certificate of analysis: Human Embryonic Stem Cell Protocols KURSAD TURKSEN, 2008-02-04 A comprehensive collection of diverse techniques for the molecular and cellular manipulation of human embryonic stem (hES) cells. These readily reproducible methods have been optimized for the derivation, characterization, and differentiation of hES cells, with special attention given to regenerative medicine applications. A companion CD provides color versions of all illustrations in the book. The protocols follow the successful Methods in Molecular BiologyTM series format, each offering step-by-step laboratory instructions, an introduction outlining the principles behind the technique, lists of the necessary equipment and reagents, and tips on troubleshooting and avoiding known pitfalls. |
| becton dickinson certificate of analysis: Molecular Methods for Virus Detection Danny L. Wiedbrauk, Daniel H. Farkas, 1995-02-08 Molecular diagnostic procedures have been described in a number of recent books and articles. However, these publications have not focused on virus detection, nor have they provided practical protocols for the newer molecular methods. Written by the inventors or principal developers of these technologies, Molecular Methods for Virus Detection provides both reviews of individual methods and instructions for detecting virus nucleic acid sequences in clinical specimens. Each procedure includes quality assurance protocols that are often ignored by other methodology books. Molecular Methods for Virus Detection provides clinically relevant procedures for many of the newer diagnostic methodologies. - Provides state-of-the-art PCR methods for amplification, quantitation, in situ hybridization, and multiplex reactions - Goes beyond PCR with protocols for 3SR, NASBA, LCR, SDA, and LAT - Covers important virus detection methods such as in situ hybridization; Southern, dot, and slot blots; branched chain signal amplification; and chemiluminescence - Includes quality control information crucial in research and clinical laboratories - Most chapters are written by the inventors and principal developers of the methodologies - Includes color plates, 77 figures, and 18 tables |
| becton dickinson certificate of analysis: Innate Immunity Jonathan Ewbank, Eric Vivier, 2008 Immunologists today are interested in all of the diverse cell-types involved in host defense and have a deeper appreciation of the importance of innate immune mechanisms as a first line of protection against pathogens. This volume thus discusses the isolation and functional characterization of cells involved in innate immunity in mouse and man, including mast cells and eosinophils. Other focuses include natural killer cells, methods in statistics, in vivo imaging, genome engineering, and mutagenesis and culture that are adapted to the study of innate immunity in these hosts. These are complemented with a series of chapters dealing with alternative models: plants, worms, mosquitoes, flies, and fish. Together, these approaches and models are being used to dissect the complex interplay between hosts and pathogens and contribute to developing strategies to help fight infection. With chapters written by experts on the cutting-edge of this technology, Innate Immunity is an essential reference for immunologists, histologists, geneticists, and molecular biologists. |
| becton dickinson certificate of analysis: Targeting the Immune System to Treat Hepatitis B Virus Infection Mengji Lu, Zhongji Meng, Jia Liu, Anna D. Kosinska, 2022-04-06 |
| becton dickinson certificate of analysis: Flow Cytometry Marion G. Macey, 2007-11-03 Flow cytometry forms an integral part of both basic biological research and clinical diagnosis in pathology. This straightforward new volume provides a clear, easy-to-read, and practical manual for both clinicians and non-clinicians at all levels of their careers. The chapter topics range from basic principles to more advanced subjects, such as apoptosis and cell sorting. The book charts the history, development and basic principles of flow cytometry. |
| becton dickinson certificate of analysis: Exposure to Prenatal Psychosocial Stress Sonja Entringer, 2007 |
| becton dickinson certificate of analysis: Federal Supply Catalog United States. Department of Veterans Affairs. Office of Acquisition and Materiel Management, 1991 |
| becton dickinson certificate of analysis: Flow Cytometry Today Claudio Ortolani, 2022-11-16 This book covers all the technical aspects of flow cytometry needed to set-up the instrument, solve problems encountered in daily work, or necessary for exam preparation. It provides the reader with an in-depth look at the device and its applications. Each component and its function is described in an easy-to-understand manner, giving the reader a sound basic knowledge of this instrument. The practical examples given, simplify and enhance the learning process. This book is a unique resource of knowledge for biomedical engineers and biotechnologists, flow cytometry operators, laboratory technicians and biomedical researchers, both biologists as well as medical doctors, and can also be a helpful tool for companies and manufacturers. |
| becton dickinson certificate of analysis: Scott Paper Company V. Fort Howard Paper Company , 1970 |
| becton dickinson certificate of analysis: Developments in Bovine Immunology - An Integrated View Kieran G. Meade, 2015-07-22 The world’s population is predicted to hit 9 Billion by 2050, and with it food demand is predicted to increase substantially. The World Bank estimates that cereal and meat production needs to increase by 50% and 85% respectively between 2000 and 2030 to meet demand, putting serious pressure on the global agricultural industry. Critical to meeting this demand for food are mechanisms to reduce the incidence of animal disease. With in excess of 1.3 billion cattle globally, the total cost of infectious diseases is difficult to estimate. However in North America alone, the cost is predicted to be $18 billion annually. Non-infectious diseases also account for another major impediment to the production capacity and welfare of animals as well as the economic sustainability of farming. However animal diseases have implications that spread far beyond the farm gate. Infectious agents can also contaminate the food chain, and potentially affect human health. Controlling diseases, through better preventative and treatment methods requires a detailed understanding of the immune response in livestock species. Multiple studies have identified associations between variation in immune genes and disease susceptibility, which potentially opens up new avenues to select animals with superior disease resistance. Detailed understanding of immunity in cattle is leading to the design of more effective vaccines. Furthermore, appreciation of the significant differences between rodent and human immune responses has also led to bovine models being developed for some human diseases. The publication of the bovine genome and the advent of next-generation sequencing technologies have facilitated a massive expansion in our knowledge of the immune response in cattle. As a result there has been an explosion of exciting research findings including in metagenomics and epigenetics. Recently, there has been a welcome move to integrate our emerging understanding of the immune response with detailed studies of other important physiological processes including nutrition and reproduction. The interactions between the reproductive system, nutrition and the immune system are of particular interest, since each places significant demands on the animal at various stages through the production cycle. The interplay between these morphologically diffuse systems involves widely distributed chemical signals in response to environmental input, and each system must interact for the normal functioning of the other. A comprehensive “systems” approach is improving our understanding of normal physiological interactions between these systems and furthermore, how dysregulation can lead to disease. The successful translation of bovine immunological research into improved treatments for animal disease requires tight interaction between diverse scientific and clinical disciplines including immunology, microbiology, endocrinology, physiology, nutrition, reproduction and clinical veterinary medicine. With so much recent progress in the field, we believe that it is valuable and well-timed to review the broad variety of the relevant studies that attempt to increase our understanding through comprehensive collaboration between these disciplines. We are looking forward to a wide and vivid discussion of developments in bovine immunology and related issues, and we expect that our readers profoundly benefit from new exciting insights and fruitful collaborations. |
| becton dickinson certificate of analysis: Methods in Cyanobacterial Research Shailendra Pratap Singh, Rajeshwar P. Sinha, Donat-P. Häder, 2024-06-14 This laboratory reference compiles the essential protocols used in cyanobacterial research. Cyanobacteria is a model system for biofuel production and sequestration of carbon dioxide to tackle global climate change due to increasing levels of greenhouse gases. Topics range from identification and growth parameters to biomolecule estimation and isolation. It also covers genome analysis and bioengineering of cyanobacteria for novel products. Key Features: Provides step-by-step procedures and troubleshooting tips Covers identification, growth parameters and pigment estimation methodologies Describes isolation, characterization and purification of microcystin, phycobiliproteins and scytonemin from cyanobacteria Discusses genomics, proteomics and bioengineering of cyanobacteria from novel products Explains sample preparation and visualization protocol for electron microscopy-based analysis of cyanobacteria This collection is useful to students and researchers in life sciences. It is also meant for industry experts who are involved in the production of biofuels, biofertilizers, other value-added products, and carbon sequestration using cyanobacteria. |
| becton dickinson certificate of analysis: Corporate Giving Directory , 2007 |
| becton dickinson certificate of analysis: Journal of the Outdoor Life , 1912 |
| becton dickinson certificate of analysis: Practical Guide to Diagnostic Parasitology Lynne Shore Garcia, 2021-04-30 In the 21st century the field of diagnostic medical parasitology continues to see dramatic changes, including newly recognized pathogens and the changing endemicity and classification of familiar organisms; neglected tropical diseases and the impact of global climate change; and new methodologies and risk management issues. This classic clinical laboratory parasitology reference, now in its third edition, has been extensively revised and updated in a new full-color format. Still organized to provide maximum help to the user, particularly from the bench perspective, every section has been expanded with new images and discussion. Specimen collection, preservation, and testing options are thoroughly discussed, from the routine ova and parasite examination to blood films, fecal immunoassays, and the newer molecular test panels. Specific test procedures, laboratory methods and reagents, and algorithms are provided. The ever-helpful FAQ section of commonly asked questions now offers expanded information on stool specimen fixatives and testing, thorough coverage of new techniques, and advice on reporting and commenting on results. The heart of the Guide, covering identification of individual pathogens, has been expanded with more discussion and comparison of organisms and dozens of new color images. An entirely new section has been added that uses extensive figures and new tables to illustrate common problems with differentiating organisms from one another and from possible microscopic artifacts. The final section has been reorganized to include identification keys and dozens of tables summarizing organism characteristics to assist the bench microbiologist with routine diagnostic testing methods. |
| becton dickinson certificate of analysis: Phage Therapy: Past, Present and Future Stephen T. Abedon, Pilar García, Peter Mullany, Rustam Aminov, 2017-09-05 Historically, the first observation of a transmissible lytic agent that is specifically active against a bacterium (Bacillus anthracis) was by a Russian microbiologist Nikolay Gamaleya in 1898. At that time, however, it was too early to make a connection to another discovery made by Dmitri Ivanovsky in 1892 and Martinus Beijerinck in 1898 on a non-bacterial pathogen infecting tobacco plants. Thus the viral world was discovered in two of the three domains of life, and our current understanding is that viruses represent the most abundant biological entities on the planet. The potential of bacteriophages for infection treatment have been recognized after the discoveries by Frederick Twort and Felix d’Hérelle in 1915 and 1917. Subsequent phage therapy developments, however, have been overshadowed by the remarkable success of antibiotics in infection control and treatment, and phage therapy research and development persisted mostly in the former Soviet Union countries, Russia and Georgia, as well as in France and Poland. The dramatic rise of antibiotic resistance and especially of multi-drug resistance among human and animal bacterial pathogens, however, challenged the position of antibiotics as a single most important pillar for infection control and treatment. Thus there is a renewed interest in phage therapy as a possible additive/alternative therapy, especially for the infections that resist routine antibiotic treatment. The basis for the revival of phage therapy is affected by a number of issues that need to be resolved before it can enter the arena, which is traditionally reserved for antibiotics. Probably the most important is the regulatory issue: How should phage therapy be regulated? Similarly to drugs? Then the co-evolving nature of phage-bacterial host relationship will be a major hurdle for the production of consistent phage formulae. Or should we resort to the phage products such as lysins and the corresponding engineered versions in order to have accurate and consistent delivery doses? We still have very limited knowledge about the pharmacodynamics of phage therapy. More data, obtained in animal models, are necessary to evaluate the phage therapy efficiency compared, for example, to antibiotics. Another aspect is the safety of phage therapy. How do phages interact with the immune system and to what costs, or benefits? What are the risks, in the course of phage therapy, of transduction of undesirable properties such as virulence or antibiotic resistance genes? How frequent is the development of bacterial host resistance during phage therapy? Understanding these and many other aspects of phage therapy, basic and applied, is the main subject of this Topic. |
| becton dickinson certificate of analysis: Dun & Bradstreet Reference Book of Corporate Managements Dun and Bradstreet, inc, 1977 |
| becton dickinson certificate of analysis: HIV, Perinatal Infections, and Therapy Richard Kermit Miller, Henry A. Thiede, 1994 Papers on the role of the placenta in HIV and other perinatal infections. Proceedings from the 12th Rochester Trophoblast Conference, held in Autumn 1992 in Rochester, New York. The first part of the book addresses the role of the placenta in the transmission of the HIV infection, the central focus of the Conference. Other pre-natal infections, including CMV, Vaccina, Parvovirus, Syphillis, and Herpes Simplex, are then considered, and their implications for perinatal health investigated. The importance of cell regulation is alsodiscussed, exploring the controlling factors which modulate the placental cell membrane and metabolic functions, such as genetic imprinting; the regulation of arachidonic acid cascade; autocrine role for human chorionic gonadotropin; biochemical screening for Down's Syndrome; the role of growth factors and interferon; the autoregulation of gas exchange; and the role of uterine cytokines. HENRY THIEDE is Professor of Obstetrics and Gynecology at the University of Rochester. RICHARD K. MILLERteaches in the University of Rochester Medical Center. |
| becton dickinson certificate of analysis: Interstate Commerce Commission Reports United States. Interstate Commerce Commission, 1965 |
| becton dickinson certificate of analysis: Manual of Molecular and Clinical Laboratory Immunology John L. Schmitz, Barbara Detrick, Maurice R. O'Gorman, 2024-12-24 THE authoritative guide for clinical laboratory immunology For nearly 50 years, the Manual of Molecular and Clinical Laboratory Immunology has been the premier resource for laboratories, students, and professionals involved in the clinical and technical details of diagnostic immunology testing. The 9th Edition continues its tradition of providing comprehensive clinical and technical information on the latest technologies used in medical and diagnostic immunology. Led by a world-renowned group of authors and editors, this new edition reflects substantial changes aimed at improving and updating the Manual’s utility while reflecting the significant transformations that have occurred since the last edition, including the revolution of gene editing and the widespread adoption of molecularly engineered cellular therapies. Topical highlights include: Laboratory Management: three new chapters cover essential aspects of quality assurance, quality improvement, and quality management, aligning with the increasingly stringent and demanding regulatory environment. Inborn Errors of Immunity: the primary immunodeficiency section has been completely updated to align with the latest International Union of Immunological Societies’ classifications of inborn errors of immunity. Functional Cellular Assays: expanded content includes detailed discussions on various functional assays critical for modern immunologic testing. Autoimmune Diseases: expanded chapters on systemic and organ-specific autoimmune disorders, including new chapters on Sjögren’s syndrome and deficiency of ADA2, as well as significant updates on organ-specific autoimmune diseases. Transplantation Immunology: updated chapters detail the assessment of immune reconstitution and ABO testing, reflecting latest practices. The 9th Edition of the Manual of Molecular and Clinical Laboratory Immunology serves as an invaluable resource for laboratory directors, clinicians, laboratory managers, technologists, and students. It provides critical insights into the selection, application, and interpretation of immunologic tests, offering practical guidance on troubleshooting, clinical application, and an understanding of test limitations. This comprehensive and up-to-date manual remains an essential tool for anyone involved in the diagnosis, evaluation, and management of immune-mediated and immune system-related disorders. |
| becton dickinson certificate of analysis: NIOSH Publications Catalog National Institute for Occupational Safety and Health, 1985 |
| becton dickinson certificate of analysis: New insights into innate immune cell-based immunotherapies in cancer Mary Poupot-Marsan, Anne Caignard, Daniela Wesch, Virginie Lafont, Chiara Porta, 2024-04-17 |
Certificate of Analysis
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis - Thermo Fisher Scientific
BD Biosciences Advanced Bioprocessing Certificates of Analysis (COA)typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis Becton Dickinson and Company BD …
BD Diagnostics - Diagnostic Systems’ Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis
BD Diagnostic Systems is an ISO 13485:2016 Registered facility. BD Diagnostics - Diagnostic Systems products are manufactured in facilities registered with the United States Food and …
Certificate of Analysis - Thermo Fisher Scientific
BD Biosciences Advanced Bioprocessing Certificates of Analysis (COA)typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis - Fisher Sci
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis Becton Dickinson and Company BD …
BD Diagnostics - Diagnostic Systems’ Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis Becton Dickinson and Company BD …
BD Diagnostic Systems’ Certificates of Analysis (COA) typically are set up to contain animal origin information for finished products manufactured using materials of animal origin.
Certificate of Analysis
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis
The batch number on this certificate is synonymous with the Lot Number shown on the product label. Any test results reported on this certificate were obtained
Certificate of Analysis Becton Dickinson and Company BD …
BD Diagnostics - Diagnostic Systems’ Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis
BD Diagnostics - Diagnostic Systems’ Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis - Thermo Fisher Scientific
BD Biosciences Advanced Bioprocessing Certificates of Analysis (COA)typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis - Thermo Fisher Scientific
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis - Fisher Sci
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis
BD Biosciences Advanced Bioprocessing Certificates of Analysis (COA)typically contain animal origin information when products are manufactured using materials of animal origin.
Certificate of Analysis - Fisher Sci
BD Diagnostics - Diagnostic Systems' Certificates of Analysis (COA) typically contain animal origin information when products are manufactured using materials of animal origin.
SAFETY DATA SHEET
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 1.0 Last revised date: 07.06.2024 SDS_GB 1/17 SAFETY DATA SHEET Classification …
Material Safety Data Sheet - BD
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 1.0 Last revised date: 09.07.2024 SDS_GB 4/14 Technical measures: No data available. …
SAFETY DATA SHEET
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 1.1 Last revised date: 30.07.2024 SDS_GB 3/17
SAFETY DATA SHEET
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 2.4 Revision Date: 25.05.2021 SDS_GB 1/22 SAFETY DATA SHEET According to Regulation …
SAFETY DATA SHEET
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 1.0 Revision Date: 19.05.2021 SDS_GB 1/66 SAFETY DATA SHEET According to Regulation …
SAFETY DATA SHEET - BD
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 1.2 Last revised date: 25.04.2025 SDS_GB
SAFETY DATA SHEET
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 1.1 Last revised date: 09.01.2025 SDS_GB 3/37 740046
Material Safety Data Sheet - BD
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Date: 18.01.2019 2 /2 Special precautions for user: Not regulated. IATA UN Number: UN 3316 …
SAFETY DATA SHEET - BD
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 2.6 Last revised date: 12.06.2023 5/18 SDS_GB 6.2 Environmental Precautions: Avoid release to …
SAFETY DATA SHEET - BD
Becton, Dickinson and Company BD, Franklin Lakes, NJ 07417 USA www.bd.com Version: 1.1 Last revised date: 10.09.2021 SDS_GB 1 /21 SAFETY DATA SHEET According to Regulation …
